Evidence for acute stimulation of fibrinogen production by glucagon in humans

Diabetes

Volumn 46, Issue 8, 1997, Pages 1368-1371

  Tessari, P ^a,b   Iori, E ^a   Vettore, M ^a   Zanetti, M ^a   Kiwanuka, E ^a   Davanzo, G ^a   Barazzoni, R ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOISOCAPROIC ACID; ACUTE PHASE PROTEIN; FIBRINOGEN; GLUCAGON; GROWTH HORMONE; INSULIN; LEUCINE; PHENYLALANINE; SOMATOSTATIN; TYROSINE;

ADULT; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HYPERGLUCAGONEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SECRETION; STIMULATION; STRESS;

EID: 0030835886     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.8.1368     Document Type: Article

References (37)

1. Gordon AH: The acute phase plasma proteins. In Plasma Protein Turnover. Bianchi R, Mariani G, Mcfarlane AS, Eds. Baltimore, MD, Univ. Park Press, 1976, p. 381-394
2. Kannel WB, Wolf PA, Castelli WP, D'Agostino RB: Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA 258:1183-1186, 1987
3. Ernst E: Fibrinogen: an independent risk factor for cardiovascular disease. Br Med J 303:596-597, 1991
4. Ceriello A, Taboga C, Giacomello R, Falleti E, De Stasio G, Motz E, Lizzio S, Gonano F, Bartoli E: Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes 43:430-342, 1994
5. Ernst E, Matray A, Schmolz C, Magyarosy I: Dose-effect relationship between smoking and blood rheology. Br J Haematol 65:485-491, 1987
6. Morimoto R, Tissieres A, Georgopoulos C (Eds.): Stress Proteins in Biology and Medicine. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1990
7. Ganda OP, Arkin CF: Hyperfibrinogenia: an important risk factor for vascular complications in diabetes. Diabetes Care 15:1245-1250, 1992
8. De Feo P, Gaisano MG, Haymond MW: Differential effects of insulin deficiency on albumin and fibrmogen synthesis in humans. J Clin Invest 88:833-840, 1991
9. De Feo P, Volpi E, Lucidi P, Cruciani G, Reboldi G, Siepi D, Mannarino E, Santeusanio F, Brunetti P, Bolli G: Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans. Diabetes 42:995-1002, 1993
10. Unger RH: Glucagon and insulin:glucagon ratio in diabetes and the other catabolic illness. Diabetes 20:834-838, 1972
11. Russel RCG, Walker CJ, Bloom SR: Hyperglucagonemia in the surgical patient. Br Med J 1:10-12, 1975
12. Tessari P, Inchiostro S, Barazzoni R, Zanetti M, Vettore M, Biolo G, Iori E, Kiwanuka E, Tlengo A: Hyperglucagonemia stimulates phenylalanine oxidation in man. Diabetes 45:463-470, 1996
13. Tessari P, Inchiostro S, Vettore M, Sabadin L, Biolo G: A fast HPLC method for the measurement of plasma concentration and specific activity of phenylalanine. Clin Biochem 24:425-428, 1991
14. Nissen SL, Van Huysen C, Haymond MW: Measurement of branched-chain ammo acids and branched-chain α-ketoacids in plasma by high-performance liquid chromatography. J Chromatogr 232:170-175, 1982
15. Tessari P, Barazzoni R, Zanetti M, Vettore M, Normand S, Bruttomesso D, Beaufrere B: Protein degradation and synthesis measured with multiple amino acid tracers in vivo. Am J Physiol 271:E733-E741, 1996
16. Schwenk WF, Berg PJ, Beaufrere B, Miles JM, Raymond MW: Use of t-butyl-dimethylsilylation in the GC/MS analysis of physiologic compounds found in plasma using electron impact ionization. Anal Biochem 141:101-109, 1984
17. Horber FF, Kahl J, Lecavalier L, Krom B, Haymond MW: Determination of leucine and α-ketoisocaproic acid concentrations and specific activity in plasma and of leucine specific activity in proteins using high performance liquid chromatography. J Chromatogr 495:81-94, 1989
18. Millward DJ, Price GM, Pacy PJH, Halliday D: Whole body protein turnover what can we measure with confidence? Proc Nutr Soc 50:195-214, 1991
19. 13C]tyrosine in the postabsorptive state. Metabolism 31:999-1005, 1982
20. 5]phenylalanine model. Am J Physiol 256:E631-E639, 1989
21. Rosenberg LE, Scriver CR: Disorders of amino acid metabolism. In Metabolic Control and Disease. Bondy PK, Rosenberg LE, Eds. Philadelphia, Saunders, 1980, p. 707-710
22. Lickley HLA, Kemmer FW, Wasserman DH, Vranic M: Glucagon and its relationship to other glucoregulatory hormones in exercise and stress in normal and diabetic subjects. In Glucagon. Vol II. Lefèbvre PJ, Ed. Berlin, Springer, 1983, p. 297-350
23. Carraro F, Hartl WH, Stuart CA, Layman DK, Jahoor F, Wolfe RR: Whole-body and plasma protein synthesis in exercise and recovery in human subjects. Am J Physiol 258:E821-E831, 1990
24. McMillan DE: Clotting disorders in diabetes. In International Textbook of Diabetes Mellitus. Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, Eds. New York, Wiley, 1992, p. 1447-1457
25. Miller LL, Griffin EE: Regulation of net biosynthesis of albumin, fibrinogen, α-1 acid glycoprotein, α-2 (acute phase) globulin and aptoglobin by direct action of hormones on the isolated perfused liver. In Biochemical Actions of Hormones. Litwak G, Ed. New York, Academic, 1975, p. 159-186
26. O'Riodain MG, Ross JA, Fearon KG, Maingay J, Farouk M, Garden OJ, Carter DC: Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol 269:E323-E330, 1995
27. Rosenfeld BA, Faraday N, Campbell D, Dise K, Bell W, Goldschmidt P: Hemostatic effects of stress hormone infusion. Anesthesiology 81:1116-1126, 1994
28. Ceriello A, Quatraro A, Marchi E, Barbanti M, Dello Ruddo P, Lefebvre PJ: The role of hyperglycemia-induced alterations of antithrombin III and factor X activation in the thrombin hyperactivity of diabetes mellitus. Diabet Med 7:343-348, 1990
29. Ritchie DG, Levy BA, Adams MA, Fuller GM: Regulation of fibrinogen synthesis by plasmin-derived fragments of fibrinogen and fibrin: an indirect feedback pathway. Proc Natl Acad Sci USA 79:1530-1534, 1982
30. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 241:2035-2038, 1979
31. Parhofer KG, Hugh P, Barrett R, Bier DM, Schonfeld G: Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes. J Lipid Res 32:1311-1323, 1991
32. Cryer DR, Matsushima T, Marsh JB, Yudkoff M, Coates PM, Cortner JA: Direct measurement of apolipoprotein B synthesis in human very low density lipoprotein using stable isotopes and mass spectrometry. J Lipid Res 27:508-516, 1986
33. Wolfe RR, Goodenaugh RD, Wolfe MH, Royle GT, Nadel ER: Isotopic analysis of leucine and urea metabolism in exercising humans. J Appl Physiol 52:459-466, 1982
34. Schwenk WF, Beaufrere B, Haymond MW: Use of reciprocal pool specific activities to model leucine metabolism in man. Am J Physiol 249:E646-E650, 1985
35. Bennet WM, O'Keefe JD, Haymond MW: Comparison of precursor pools with leucine, α-ketoisocaproate, and phenylalanine tracers used to measure splanchnic protein synthesis in man. Metabolism 42:691-695, 1993
36. Waterlow JC, Garlick PJ, Millward DJ: Free amino acids. In Protein Turnover in Mammalian Tissues and in the Whole Body. Waterlow JC, Garlick PJ, Millward DJ, Eds. New York, North Holland Publishing, p. 117-176
37. Cobelli C, Saccomani MP, Tessari P, Biolo G, Luzi L, Matthews DE: Compartmental model of leucine kinetics in humans. Am J Physiol 261:E539-E550, 1991